Who we are
An interdisciplinary team focusing on biotech value creation.
What we do
Our mission can be divided in two major frames:
1. Start-up creation through our investment vehicle AurorA Science (link sulla scritta), technology transfer operations and mentoring. We build close ties with project originators and deal flow partners, such as universities, research centers, technology transfer offices, biotechnology companies, patient foundations biotechnology clusters and regional funds to access promising projects in their early phase, from discovery to preclinical.
2. Deal frame & fund raising campaigns for promising biotech companies and assets.
Our focus
We are focused on the European research and academic environment with a strong bias towards scientific projects with a clear therapeutic claim, persuasive in vivo data, a solid or solid-to-be intellectual property position, a committed team with a strong track record and a partnership attitude.
Where we act
We act in Europe for the scouting and fostering of projects and globally for partnering, licensing, co-development and commercial agreements.
Bridging the gap
AurorA-TT bridges the gap between discovery/early development projects towards clinical development, market, licensing and partnerships.
AurorA-TT aims to translate research findings from academia and R&D institutes into druggable and marketable appealing assets to receive support by the venture capital community and biopharmaceutical companies.
Our model
Research projects within the Italian academic and R&D arena are scouted, sourced, incubated, accelerated, supported and presented to external partners to receive support for the execution of product development plan within project-specific companies. This gives projects the chance to reach market through out-licensing agreements with biopharmaceutical companies and through spin-off models.
Acceleration and derisking activities
AurorA-TT coordinates a set of activities over the drug development process to meet minimum requirements and achieve support from external partners.
MARKET RESEARCH
∙ Competition analysis
∙ Possible scenarios
∙ Valuation
REGULATORY ACTIVITIES
∙ Scientific advice
∙ Orphan drug designation
∙ Other ad-hoc
EXPERIMENTAL STUDIES
∙ Pharmacology
∙ Toxicology
∙ PDM
∙ Etc.
PARTNER SCOUTING
PATENTING
(if necessary)
PUBLICATION
(if necessary)
DRUG DEVELOPMENT PLAN
preparation
CLINICAL TRIALS
∙ Clinical trial design
∙ In-silico trials
∙ Benefit/Risk Sharing Agreements